- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03177486
Frank Score and Coronary Artery Disease
June 5, 2017 updated by: Liu Zhongwei, Shaanxi Provincial People's Hospital
Frank Score and Its Guidance Significance of Making Treatment Strategy in Coronary Artery Disease
Patients with coronary artery disease (CAD) were enrolled.
CAD was diagnosed by coronary angiography which also resulted Syntax score.
Images of left and right ears were captured by a digital camera.
Frank score of each patients was calculated based on characteristics and numbers of wrinkles of the earlobes.
Statistic analysis were carried out to analyze the correlation between Frank Score and Syntax Score.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
364
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710068
- Shaanxi Provincial People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Hospitalized patients receiving coronary angiography
Description
Inclusion Criteria:
- Diagnosis coronary artery disease by coronary angiography
Exclusion Criteria:
- Diagnosis of malignant tumor
- Positive heart transplant history
- Positive CABG history
- Positive PCI history
- Pregnant and lactating women
- Diagnosis of chronic kidney disease
- Any external ear trauma or disease history
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Syntax score completed
Time Frame: Up to 30 minutes after completion of coronary angiography
|
Syntax score is calculated by two experienced cardiologists according to the results of coronary angiography
|
Up to 30 minutes after completion of coronary angiography
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Follow-up MACE
Time Frame: When MACE is reported or up to 1 year after diagnosis of coronary artery disease
|
MACE is reported in follow-up patients
|
When MACE is reported or up to 1 year after diagnosis of coronary artery disease
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2015
Primary Completion (Actual)
November 18, 2016
Study Completion (Actual)
November 18, 2016
Study Registration Dates
First Submitted
May 29, 2017
First Submitted That Met QC Criteria
June 5, 2017
First Posted (Actual)
June 6, 2017
Study Record Updates
Last Update Posted (Actual)
June 6, 2017
Last Update Submitted That Met QC Criteria
June 5, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FrankSyntax
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina